Christine Chable-Bessia
- Virology top 0.2%
- HIV Research and Treatment 10
- Immunology top 1%
- interferon and immune responses 5
- T-cell and B-cell Immunology 3
- Cancer Research top 2%
- MicroRNA in disease regulation 4
- NF-κB Signaling Pathways 4
- Infectious Diseases top 2%
- Molecular Biology top 5%
- RNA Research and Splicing 4
- RNA Interference and Gene Delivery 3
- Ubiquitin and proteasome pathways 3
- Co-authors
- Monsef BenkiraneNadine LaguetteAlain IsraëlGilles CourtoisStéphane EmilianiOlivier SchwartzAhmad YatimAndrew Kovalenko
- Cited by
- VirologyImmunologyCancer Research
- Partner nations
- FranceItalyUnited States
In The Last Decade
Christine Chable-Bessia
20 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Virology 1.7k
- Immunology 1.7k
- Cancer Research 977
- Infectious Diseases 773
- Molecular Biology 2.1k
Countries citing papers authored by Christine Chable-Bessia
This map shows the geographic impact of Christine Chable-Bessia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Chable-Bessia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Chable-Bessia more than expected).
Fields of papers citing papers by Christine Chable-Bessia
This network shows the impact of papers produced by Christine Chable-Bessia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Chable-Bessia. The network helps show where Christine Chable-Bessia may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christine Chable-Bessia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2022 | 11 | |
| 3 | 2021 | 38 | |
| 4 | 2021 | 27 | |
| 5 | 2012 | 144 | |
| 6 | 2012 | 274 | |
| 7 | SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpxbreakdown → | 2011 | 1155 |
| 8 | 2011 | 82 | |
| 9 | 2009 | 94 | |
| 10 | 2009 | 1 | |
| 11 | Suppression of MicroRNA-Silencing Pathway by HIV-1 During Virus Replicationbreakdown → | 2007 | 516 |
| 12 | 2007 | 72 | |
| 13 | 2007 | 256 | |
| 14 | 2007 | 140 | |
| 15 | 2006 | 59 | |
| 16 | 2005 | 78 | |
| 17 | The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitinationbreakdown → | 2003 | 830 |
| 18 | 2003 | 152 | |
| 19 | 2003 | 241 | |
| 20 | 2003 | 13 |
About Christine Chable-Bessia
Christine Chable-Bessia is a scholar working on Virology, Cancer Research and Immunology, having authored 20 papers that have together received 4.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (10 papers), interferon and immune responses (5 papers), MicroRNA in disease regulation (4 papers), NF-κB Signaling Pathways (4 papers), RNA Research and Splicing (4 papers), RNA Interference and Gene Delivery (3 papers), Ubiquitin and proteasome pathways (3 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Virology (1.7k citations), Immunology (1.7k citations) and Cancer Research (977 citations). Christine Chable-Bessia has collaborated with scholars based in France, Italy and United States. Frequent co-authors include Monsef Benkirane, Nadine Laguette, Alain Israël, Gilles Courtois, Stéphane Emiliani, Olivier Schwartz, Ahmad Yatim, Andrew Kovalenko, Giuseppina Cantarella and David Wallach. Their work appears in journals such as Nature, Science and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.